Faculty: Chemistry

Offer details

TECHNICAL OFFER
no. 148/2025
SECTOR
pharmacy
AUTHORS
University of Gdańsk
Gdańsk University of Technology
Nencki Institute of Experimental Biology,
Polish Academy of Sciences
Medical University of Gdańsk

FACULTY
Chemistry
IP PROTECTION
The invention is protected by a patent application filed with the Polish Patent Office No. P.427146.

COMMERCIALIZATION

Spin off
, Licence
, Sale of property rights
TECHNOLOGY READINESS LEVEL
TRL 4
Technology validated in laboratory conditions.

Modified Amplification and Expression Vectors, Fusion Proteins, Composition and Their Application

The invention relates to an amplification and expression vector as well as associated fusion proteins, including PhoA-His6-polypeptide signal protein TSRGDHELLGGGAAPVGG_10, PhoA-His6-polypeptide signal protein MaIE-His6-polypeptide signal protein TSRGDHELLGGGAAPVGG_20-40, and further fusion proteins comprising His6-c-Myc-WYY-Ubiquitin linked with various signal polypeptides.

The invention also includes the use of the described amplification and expression vector for gene expression in Escherichia coli BL21 Star(DE3) in vitro, as well as a composition containing the purified fusion protein together with a pharmaceutically acceptable carrier or excipient.

Zastosowanie:

  • Biotechnology,
  • Genetic engineering,
  • Pharmacy.

Technology offer

Get in touch